,
your personalized virtual assistant to find clinical trials. Go head, 
Erica L. Mayer
Dana-Farber/Harvard Cancer Center at Dana ...Boston, Massachusetts - 02115 (617-632-4001) Dana-Farber Cancer InstituteBoston, Massachusetts - 02115 |
- CLINICAL TRIALS 3
- CONDITIONS1
- INTERVENTIONS10
- SINCE2007
Bevacizumab and Paclitaxel Paclitaxel Albumin-Stabilized Nanoparticle Formulation or Ixabepilone in Treating Patients With Stage IIIC or Stage IV Breast Cancer
October 2008 - October 2010
Platinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response
June 2007 - June 2011
Bevacizumab Metronomic Chemotherapy (CM) Diet and Exercise After Preoperative Chemotherapy for Breast Cancer
September 2010 - September 2011
Breast Neoplasms
Exercise Intervention
Paclitaxel
Carboplatin
Bevacizumab
Cisplatin
Cyclophosphamide
Methotrexate
Ixabepilone
Paclitaxel Albumin-Stabilized Nanoparticle Formulation
Diet Intervention
